Thrombolex Announces
a Two Year Agreement with
Premier, Inc.
NIH-Funded IDE RESCUE* Clinical Trial Review -
Optimal Thrombus Burden Resolution
with Excellent Safety Results
*Investigational device, Limited by Federal Law to investigational use for this indication.
*Investigational device, Limited by Federal Law to investigational USE for this indication.
IDE RESCUE* Clinical Trial Review - Optimal Thrombus
Burden Resolution with Excellent Safety Results
Robert Lookstein M.D.
Akhilesh Sista M.D., FSIR, FAHA
John Moriarty M.D., RPVI
Vlad Lakhter D.O.
THANK YOU.
TOPIC:
Pharmaco-Mechanical Catheter-Directed Thrombolysis:
The BASHIR™ Endovascular Catheter for
Intermediate-Risk Acute Pulmonary Embolism*
Sunday, November 6, 2022
@ 10:00 a.m. CST
Health Innovation Pavilion, Heart Hub
Science and Technology Hall - Level 3
Presenter - Riyaz Bashir M.D., FACC, RVT
McCormick Place Convention Center
2301 S. King Drive, Chicago
*Investigational device, Limited by Federal Law
to investigational USE for this indication.
McCormick Place Convention Center
2301 S. King Drive, Chicago
Late-Breaking Innovation Session
A Prospective Multicenter Trial of Pharmaco-Mechanical
Catheter-Directed Thrombolysis with the
BASHIR™ Endovascular Catheter for Intermediate-Risk
Acute Pulmonary Embolism - The RESCUE Study
VEINS 2022 - October 30 & 31, 2022
The Wynn Las Vegas, Margaux 1 Exhibit Hall
3131 Las Vegas Boulevard South, Las Vegas, NV
Visit Booth #10
Industry Session:
Novel Catheter-based Therapy
for Acute Pulmonary Embolism
The NIH-funded IDE RESCUE Trial*
*Investigational device, Limited by Federal Law to investigational use for this indication.
VEINS 2022 - October 30 & 31, 2022
The Wynn Las Vegas, Margaux 1 Exhibit Hall
3131 Las Vegas Boulevard South, Las Vegas, NV
Visit Booth #10
*Investigational device, Limited by Federal Law to investigational use for this indication.